Skip to main content
Back to Trials
NCT07566286NARecruitingAccepts Healthy Volunteers

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Galderma R&D

Start Date

6/3/2026

Completion Date

2/28/2028

Summary

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Eligibility Criteria

Age Range: 22 years to No maximum

Inclusion Criteria: 1. Males or non-pregnant, non-breastfeeding females, 22 years of age or older. 2. Intent to receive treatment for augmentation and correction of retrusion in the chin region. Exclusion Criteria: 1. Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins. 2. Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics. 3. Previous or present multiple allergies or severe allergies, such as manifested by anaphylaxis or angioedema, or family history of these conditions. 4. Previous facial surgery (including facial aesthetic surgery and liposuction), below the level of the horizontal line from subnasale. 5. Any previous aesthetic procedures or implants. 6. Presence of any disease or lesions near or on the area to be treated.

Interventions

DEVICE

Restylane Lyft with Lidocaine

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Chin Augmentation

Locations

Galderma Investigational Site # 8680

Westport, Connecticut 06880

United States

Galderma Investigational Site # 8774

Boynton Beach, Florida 33437

United States

Galderma Investigational Site # 7030

Coral Gables, Florida 33134

United States

Galderma Investigational Site # 8682

Coral Gables, Florida 33134

United States

Galderma Investigational Site # 7042

Atlanta, Georgia 30331

United States

Galderma Investigational Site # 7043

Bethesda, Maryland 20852

United States

Galderma Investigational Site # 7118

Nashville, Tennessee 37203

United States

Galderma Investigational Site # 8662

Spring, Texas 77388

United States